Research marks the first time liquid biopsy has been used in lung cancer patients to determine patients likely to respond to PD-1 inhibitors
Later this year, combined company plans to launch QIAstat-Dx, designed for use in oncology and respiratory or gastrointestinal infections
The buyout enhances ICON's molecular diagnostic testing while expanding its testing platforms to include next-generation sequencing and IHC
Roche has acquired Signature Diagnostics for an undisclosed price. The deal is designed to strengthen Roche’s cancer diagnostics effort with Signature’s expertise in both...
Clinicians need to understand the implications of genetic tests quickly and in clinical context.
All payers agreed with two of the five identified factors: Panels do not fit within current coverage frameworks and lack necessary evidence.
Mastermind is designed to link data on DNA mutations with journal citations, and to date has indexed nearly 6 million scientific articles
The Ion GeneStudio S5 series' multichip design offers flexibility, while Oncomine portfolio adds liquid biopsy and immuno-oncology assays
New research could provide valuable information for understanding the genomic and phenotypic underpinnings of bacterial evolution.
Research partnership also aims to expand applicability of a point-of-care testing device for transplants to other organs other than lungs